Author(s): K. Hariprasath*, K. Vamsi Krishna, P. Venkatesh, Ch. Ratnaji and K.K.Sravanthi
Diabetes mellitus is chronic metabolic disorder affecting millions of people worldwide. The treatment approach involves different mechanisms. Out of which treating diabetes with biguanide derivative viz. metformin is a reliable one for obese patients who having risk of attaining body weight. Clinical evidence suggests that by using metformin which lowers the risk of cancer in diabetic people. This paper reveals about the beneficial role of a anti-diabetic drug as an effective anticancer drug.